Odyssey Health (ODYY) Operating Income (2014 - 2026)
Odyssey Health (ODYY) reported Operating Income of -$297554.0 for Q2 2026, down 130.56% year-over-year from $973553.2 in Q2 2025, and down 63.54% sequentially from -$181942.0 in Q1 2026.
Odyssey Health (ODYY) Operating Income (2014 - 2026) Analysis & Trends
Odyssey Health has disclosed Operating Income across 13 years of filings, most recently posting -$297554.0 for Q2 2026.
- Quarterly Operating Income fell 130.56% year-over-year to -$297554.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$938364.0 (down 49.51% YoY) and the FY2025 annual result came in at -$1.0 million, up 52.29% from the prior year.
- Operating Income fell to -$297554.0 in Q2 2026, from -$181942.0 in the prior quarter.
- Across five years, Operating Income topped out at $237431.0 in Q3 2024 and bottomed at -$2.9 million in Q2 2022.
- The 5-year median for Operating Income is -$475899.0 (2024), against an average of -$857458.5.
- Year-over-year, Operating Income slumped 211.77% in 2022 and surged 136.24% in 2024.
- Odyssey Health's Operating Income stood at -$2.1 million in 2022, then jumped by 83.29% to -$347239.0 in 2023, then tumbled by 66.87% to -$579427.0 in 2024, then soared by 47.67% to -$303190.0 in 2025, then increased by 1.86% to -$297554.0 in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$297554.0, -$181942.0, and -$303190.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 282.15 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 316.80 Mn |
| 10 | Odyssey Health | - | - | - | -297,554.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -297,554.00 |
| Jan 31, 2026 | -181,942.00 |
| Oct 31, 2025 | -303,190.00 |
| Jul 31, 2025 | -155,678.00 |
| Apr 30, 2025 | -129,055.00 |
| Jan 31, 2025 | -156,593.00 |
| Oct 31, 2024 | -579,427.00 |
| Jul 31, 2024 | 237,431.00 |
| Apr 30, 2024 | -372,371.00 |
| Jan 31, 2024 | -1.16 Mn |
| Oct 31, 2023 | -347,239.00 |
| Jul 31, 2023 | -655,108.00 |
| Apr 30, 2023 | -1.09 Mn |
| Jan 31, 2023 | -1.49 Mn |
| Oct 31, 2022 | -2.08 Mn |
| Jul 31, 2022 | -1.83 Mn |
| Apr 30, 2022 | -2.87 Mn |
| Jan 31, 2022 | -1.98 Mn |
| Oct 31, 2021 | -1.43 Mn |
| Jul 31, 2021 | -2.61 Mn |